Identification of distinctive protein expression patterns in colorectal adenoma

Proteomics - Clinical Applications

Volumn 4, Issue 1, 2010, Pages 60-70

  Lam, Francis F ^a   Jankova, Lucy ^b   Dent, Owen F ^a   Molloy, Mark P ^c   Kwun, Sun Young ^d   Clarke, Candice ^d   Chapuis, Pierre ^a   Robertson, Graham ^b   Beale, Philip ^d   Clarke, Stephen ^a   Bokey, E Les ^a   Chan, Charles ^d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ANZAC RESEARCH INSTITUTE   (Australia)

^c MACQUARIE UNIVERSITY   (Australia)

^d Department of Microbiology and Infectious Diseases   (Australia)

Author keywords

2 DE; Colorectal adenoma; Colorectal cancer

Indexed keywords

FATTY ACID BINDING PROTEIN; GALECTIN 1; GLYCEROPHOSPHOINOSITOL INOSITOLPHOSPHODIESTERASE; INITIATION FACTOR 5A; PROTEIN S 100; PROTEIN S 100A11; PROTEIN S 100A9; PROTEIN S 100P; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL METABOLISM; CELL PROLIFERATION; CLINICAL ARTICLE; COLON MUCOSA; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECTUM MUCOSA; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; COLORECTAL NEOPLASMS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUCOUS MEMBRANE; PROTEOME; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; YOUNG ADULT;

EID: 77951749690     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.200900084     Document Type: Article

References (66)

1. Vogelstein, B., Fearon, E.R., Hamilton, S.R., Kern, S.E. et al., Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 1988, 319, 525-532.
2. Jass, J.R., Do all colorectal carcinomas arise in preexisting adenomas? World J. Surg. 1989, 13, 45-51.
3. Thorsrud, A.K., Vatn, M.H., Jellum, E., Two-dimensional electrophoretic patterns of proteins of normal mucosa, polyps, and carcinomas of the large intestine. Clin. Chem. 1982, 28, 884-889.
4. Melis, R., White, R., Characterization of colonic polyps by two-dimensional gel electrophoresis. Electrophoresis 1999, 20, 1055-1064.
5. Stulik, J., Koupilova, K., Osterreicher, J., Knizek, J. et al., Protein abundance alterations in matched sets of macroscopically normal colon mucosa and colorectal carcinoma. Electrophoresis 1999, 20, 3638-3646.
6. 2+ binding S100A6 protein in normal, preneoplastic and neoplastic colon mucosa. Eur. J. Cancer 2000, 36, 1050-1059.
7. Stulik, J., Hernychova, L., Porkertova, S., Knizek, J. et al., Proteome study of colorectal carcinogenesis. Electrophoresis 2001, 22, 3019-3025.
8. Roblick, U.J., Hirschberg, D., Habermann, J.K., Palmberg, C. et al., Sequential proteome alterations during genesis and progression of colon cancer. Cell. Mol. Life Sci. 2004, 61, 1246-1255.
9. Kwong, K.Y., Bloom, G.C., Yang, I., Boulware, D. et al., Synchronous global assessment of gene and protein expression in colorectal cancer progression. Genomics 2005, 86, 142-158.
10. Habermann, J.K., Bader, F.G., Franke, C., Zimmermann, K. et al., From the genome to the proteome-biomarkers in colorectal cancer. Langenbecks Arch. Surg. 2008, 393, 93-104.
11. Chan, C., Warlow, R., Chapuis, P., Newland, R., Bokey, E.L., Immobiline-based two-dimensional gel electrophoresis: an optimised protocol for resolution of human colonic mucosal proteins. Electrophoresis 1999, 20, 3467-3471.
12. Neuhoff, V., Arold, N., Taube, D., Ehrhardt, W., Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis 1988, 9, 255-262.
13. Whitfield, J.F., Bird, R.P., Chakravarthy, B.R., Issacs, R.J., Morley, P., Calcium-Cell cycle regulator, differentiator, killer, chemopreventor, and maybe, tumor promoter. J. Cell. Biochem. 1995, S22, 74-91.
14. Stulik, J., Osterreicher, J., Koupilova, K., Knizek, J. et al., The analysis of S100A9 and S100A8 expression in matched sets of macroscopically normal colon mucosa and colorectal carcinoma: The S100A9 and S100A8 positive cells underlie and invade tumor mass. Electrophoresis 1999, 20, 1047-1054.
15. Sanjuan, X., Fernandez, P.L., Castells, A., Castronovo, V. et al., Differential expression of galectin 3 and galectin 1 in colorectal cancer progression. Gastroenterology 1997, 113, 1906-1915.
16. Park, J.E., Lee, D.H., Lee, J.A., Park, S.G. et al., Annexin A3 is a potential angiogenic mediator. Bioch. Biophys. Res. Commun. 2005, 337, 1283-1287.
17. Kim, Y.M., Kim, H.J., Song, E.J., Lee, K.J., Glucuronic acid is a novel inducer of heat shock response. Mol. Cell. Biochem. 2004, 259, 23-33.
18. Harashima, M., Niimi, S., Koyanagi, H., Hyuga, M. et al., Change in annexin A3 expression by regulatory factors of hepatocyte growth in primary cultured rat hepatocytes. Biol. Pharm. Bull. 2006, 29, 1139-1143.
19. Kasamatsu, A., Uzawa, K., Nakashima, D., Kouzu, Y. et al., A proteomics approach to characterizing human submandibular gland cell lines by fluorescent two-dimensional differential ingel electrophoresis. Int. J. Mol. Med. 2006, 17, 253-260.
20. Shekouh, A.R., Thompson, C.C., Prime, W., Campbell, F. et al., Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma. Proteomics 2003, 3, 1988-2001.
21. Friedman, D., Hill, S., Keller, J., Merchant, N. et al., Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics 2004, 4, 793-811.
22. Taylor, C.A., Sun, Z., Cliche', D. O., Ming, H. et al., Eukaryotic translation initiation factor 5A induces apoptosis in colon cancer cells and associates with the nucleus in response to tumour necrosis factor alpha signalling. Exp. Cell Res. 2007, 313, 437-449.
23. Guan, X.Y., Sham, J.S., Tang, T.C., Fang, Y. et al., Isolation of a novel candidate oncogene within a frequent amplified region at 3q26 in ovarian cancer. Cancer Res. 2001, 61, 3806-3809.
24. Clement, P.C., Henderson, C.A., Jenkins, Z.A., Smit-McBride, Z. et al., Identification and characterization of eukaryotic initiation factor 5A-2. Eur. J. Biochem. 2003, 147, 4254-4263.
25. Cracchiolo, B.M., Heller, D.S., Clement, P.M., Wolff, E.C. et al., Eukaryotic initiation factor 5A-1 (eIF5A-1) as a diagnostic marker for aberrant proliferation in intraepithelial neoplasia of the vulva. Gynecol. Oncol. 2004, 91, 217-222.
26. Oue, N., Hamai, Y., Mitani, Y., Matsumura, S. et al., Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res. 2004, 64, 2397-2405.
27. Tomasetto, C., Regnier, C., Moog-Lutz, C., Mattei, M.G. et al., Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11-q21.3 region of chromosome 17. Genomics 1995, 28, 367-376.
28. Kanamori, T., Takakura, K., Mandai, M., Kariya, M. et al., Increased expression of calcium-binding protein S100 in human uterine smooth muscle tumours. Mol. Hum. Reprod. 2004, 10, 735-742.
29. Ji, J., Zhao, L., Wang, X., Zhou, C. et al., Differential expression of S100 gene family in human esophageal squamous cell carcinoma. J. Cancer Res. Clin. Oncol. 2004, 130, 480-486.
30. Rehman, I., Cross, S.S., Azzouzi, A.R., Catto, J.W. et al., S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors. Br. J. Cancer 2004, 91, 739-744.
31. Memon, A.A., Sorensen, B.S., Meldqaard, P., Fokdal, L. et al., Down-regulation of S100C is associated with bladder cancer progression and poor survival. Clin. Cancer Res. 2005, 11, 606-611.
32. Rust, R., Visser, L., van der Leij, J., Harms, G. et al., High expression of calcium-binding proteins, S100A10, S100A11 and CALM2 in anaplastic large cell lymphoma. Br. J. Haematol. 2005, 131, 596-608.
33. Svasti, J., Srisomsap, C., Subhasitanont, P., Keeratichamroen, S. et al., Proteomic profiling of cholangiocarcinoma cell line treated with pomiferin from Derris malaccensis. Proteomics 2005, 5, 4504-4509.
34. Torres-Cabala, C., Bibbo, M., Panizo-Santos, A., Barazi, H. et al., Proteomic identification of new biomarkers and application in thyroid cytology. Acta Cytol. 2006, 50, 518-528.
35. Tanaka, M., Adzuma, K., Iwami, M., Yoshimoto, K. et al., Human calgizzarin; one colorectal cancer-related gene selected by a large scale random cDNA sequencing and northern blot analysis. Cancer Lett. 1995, 89, 195-200.
36. Melle, C., Ernst, G., Schimmel, B., Bleul, A. et al., Different expression of calgizzarin (S100A11) in normal colonic epithelium, adenoma and colorectal carcinoma. Int. J. Oncol. 2006, 28, 195-200.
37. Ohuchida, K., Mizumoto, K., Egami, T., Yamaguchi, H. et al., S100P is an early developmental marker of pancreatic carcinogenesis. Clin. Cancer Res. 2006, 12, 5411-5416.
38. Arumugam, T., Simeone, D.M., Van Golen, K., Logsdon, C.D., S100P promotes pancreatic cancer growth, survival, and invasion. Clin. Cancer Res. 2005, 11, 5356-5364.
39. Dowen, S.E., Crnogorac-Jurcevic, T., Gangeswaran, R., Hansen, M. et al., Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer. Am. J. Pathol. 2005, 166, 81-92.
40. Li, Y., St John, M.A., Zhou, X., Kim, Y. et al., Salivary transcriptome diagnostics for oral cancer detection. Clin. Cancer Res. 2004, 10, 8130-8131.
41. Mousses, S., Bubendorf, L., Wagner, U., Hostetter, G. et al., Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays. Cancer Res. 2002, 62, 1256-1260.
42. Diederichs, S., Bulk, E., Steffen, B., Ji, P. et al., S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer. Cancer Res. 2004, 64, 5564-5569.
43. Chao, A., Wang, T.H., Lee, Y.S., Hsueh, S. et al., Molecular characterization of adenocarcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression. Int. J. Cancer 2006, 119, 91-98.
44. Wang, G., Platt-Higgins, A., Carroll, J., de Silva Rudland, S. et al., Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients. Cancer Res. 2006, 66, 1199-1207.
45. Guerreiro Da Silva, I.D., Hu, Y.F., Russo, I.H., Ao, X. et al., S100P calcium-binding protein overexpression is associated with immortalization of human breast epithelial cells in vitro and early stages of breast cancer development in vivo. Int. J. Oncol. 2000, 16, 231-240.
46. Kita, H., Hikichi, Y., Hikami, K., Tsuneyama, K. et al., Differential gene expression between flat adenoma and normal mucosa in the colon in a microarray analysis. J. Gastroenterol. 2006, 41, 1053-1063.
47. Fuentes, M.K., Nigavekar, S.S., Arumugam, T., Logsdon, C.D. et al., RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways. Dis. Colon Rectum 2007, 50, 1230-1240.
48. Taguchi, A., Blood, D.C., del Toro, G., Canet, A. et al., Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 2000, 405, 354-360.
49. 2+-binding proteins of neutrophils and monocytes. J. Leukoc. Biol. 1993, 53, 197-204.
50. Hermani, A., De Servi, B., Medunjanin, S., Tessier, P.A., Mayer, D., S100A8 and S100A9 activate MAP kinase and NFkappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp. Cell Res. 2006, 312, 184-197.
51. Mikami, M., Yamazaki, M., Yui, S., Kinetical analysis of tumor cell death-inducing mechanism by polymorphonuclear leukocyte-derived calprotectin: involvement of protein synthesis and generation of reactive oxygen species in target cells. Microbiol. Immunol. 1998, 42, 211-221.
52. Gebhardt, C., Nemeth, J., Angel, P., Hess, J., S100A8 and S100A9 in inflammation and cancer. Biochem. Pharmacol. 2006, 72, 1622-1631.
53. Hsu, D.K., Yang, R.Y., Liu, F.T., Galectins in apoptosis. Meth. Enzymol. 2006, 417, 256-273.
54. Scott, K., Weinberg, C., Galectin-1: bifunctional regulator of cellular proliferation. Glycoconj. J. 2004, 19, 467-477.
55. Hughes, R.C., Galectins as modulators of cell adhesion. Biochimie 2001, 83, 667-676.
56. He, J., Baum, L.G., Endothelial cell expression of galectin-1 induced by prostate cancer cells inhibits T-cell transendothelial migration. Lab. Invest. 2006, 86, 578-590.
57. Chen, Y.R., Juan, H.F., Huang, H.C., Huang, H.H. et al., Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells. Proteome Res. 2006, 5, 2727-2742.
58. Camby, I., Le Mercier, M., Lefranc, F., Kiss, R., Galectin-1: A small protein with major functions. Glycobiology 2006, 16, 137R-157R.
59. Bremer, E., van Dam, G., Kroesen, B.J., de Leij, L., Helfrich, W., Targeted induction of apoptosis for cancer therapy: current progress and prospects. Trends Mol. Med. 2006, 12, 382-393.
60. Thijssen, V.L.J. L., Postel, R., Brandwijk, R.J.M. G. E., Dings, R.P.M. et al., Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc. Natl. Acad. Sci. USA 2006, 103, 15975-15980.
61. Reymond, M., Sanchez, J., Hughes, G., Gunther, K. et al., Standardized characterization of gene expression in human colorectal epithelium by two-dimensional electrophoresis. Electrophoresis 1997, 18, 2842-2848.
62. Chmurzynska, A., The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism. J. Appl. Genet. 2006, 47, 39-48.
63. Das, R., Hammamieh, R., Neill, R., Melhem, M., Jett, M., Expression pattern of fatty acid-binding proteins in human normal and cancer prostate cells and tissues. Clin. Cancer Res. 2001, 7, 1706-1715.
64. Hashimoto, T., Kusakabe, T., Watanabe, K., Sugino, T. et al., Liver-type fatty acid-binding protein is highly expressed in intestinal metaplasia and in a subset of carcinomas of the stomach without association with the fatty acid synthase status in the carcinoma. Pathobiology 2004, 71, 115-122.
65. Sorof, S., Modulation of mitogenesis by liver fatty acid binding protein. Cancer Metastasis Rev. 1994, 13, 317-336.
66. Lawrie, L.C., Dundas, S.R., Curran, S., Murray, G.I., Liver fatty acid binding protein expression in colorectal neoplasia. Br. J. Cancer 2004, 90, 1955-1960.